Free Trial

Turnstone Biologics (TSBX) Insider Trading & Ownership

Turnstone Biologics logo
$0.49 +0.03 (+6.41%)
(As of 12/20/2024 05:31 PM ET)

Turnstone Biologics (NASDAQ:TSBX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
32.10%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$7.70 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get TSBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TSBX Insider Buying and Selling by Quarter

Turnstone Biologics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/25/2023Versant Ventures V, LlcMajor ShareholderBuy225,000$12.00$2,700,000.00  
7/20/2023Rishi GuptaDirectorBuy416,666$12.00$4,999,992.00  
(Data available from 1/1/2013 forward)

TSBX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Turnstone Biologics includes Rishi Gupta, and Versant Ventures V, Llc. Learn more on insiders at TSBX.

32.10% of Turnstone Biologics stock is owned by insiders. Learn more on TSBX's insider holdings.

The following insiders have purchased TSBX shares in the last 24 months: Rishi Gupta ($4,999,992.00), and Versant Ventures V, Llc ($2,700,000.00).

Insiders have purchased a total of 641,666 TSBX shares in the last 24 months for a total of $7,699,992.00 bought.

Turnstone Biologics Key Executives

  • Dr. Sammy J. Farah M.B.A. (Age 51)
    Ph.D., President, CEO & Director
    Compensation: $820.88k
  • Dr. Venkat Ramanan Ph.D. (Age 54)
    Chief Financial Officer
    Compensation: $613.14k
  • Dr. Vijay Chiruvolu M.B.A. (Age 62)
    Ph.D., Interim Chief Technology Officer
    Compensation: $548.43k
  • Dr. Michael F. Burgess M.D. (Age 60)
    MBChB, Ph.D., Interim Chief Medical Officer & Executive Director
  • Dr. Stewart Abbot Ph.D. (Age 57)
    Chief Scientific Officer
  • Ms. Saryah Azmat (Age 34)
    Chief Business Officer
    Compensation: $479.73k


This page (NASDAQ:TSBX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners